These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1725195)

  • 1. ACE inhibition--prospects for the future. Satellite symposium to the XIIth Congress of the European Society of Cardiology. Stockholm, September 19, 1990.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-49. PubMed ID: 1725195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardioprotection through ACE inhibition. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 26 May 1988, Kyoto, Japan].
    Fortschr Med Suppl; 1988; 51():1-17. PubMed ID: 2904397
    [No Abstract]   [Full Text] [Related]  

  • 3. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
    [No Abstract]   [Full Text] [Related]  

  • 4. ACE-inhibition: state of the art. Symposium held during the Xth Congress of the European Society of Cardiology. Vienna, August 31, 1988. Proceedings.
    Cardiology; 1989; 76 Suppl 2():1-68. PubMed ID: 2766310
    [No Abstract]   [Full Text] [Related]  

  • 5. New aspects of calcium antagonism in cardiovascular disease. Proceedings of a symposium. An official satellite to the Twelfth Congress of the European Society of Cardiology. Stockholm, Sweden, September 19, 1990.
    Am Heart J; 1991 Jul; 122(1 Pt 2):307-74. PubMed ID: 1675838
    [No Abstract]   [Full Text] [Related]  

  • 6. Modern methods of investigating converting enzyme inhibition. Satellite symposium to the Xth Congress of the European Society of Cardiology. August 28 to September 1, 1988, Vienna. Proceedings.
    Am Heart J; 1989 Mar; 117(3):715-68. PubMed ID: 2919551
    [No Abstract]   [Full Text] [Related]  

  • 7. ACE inhibition and myocardial ischemia--new challenge for the third millennium. Proceedings of a satellite symposium of the XXth Congress of the European Society of Cardiology. Vienna, Austria, August 1998.
    Eur Heart J; 1998 Sep; 19 Suppl J():J1-60. PubMed ID: 9890794
    [No Abstract]   [Full Text] [Related]  

  • 8. XIIth Congress of the European Society of Cardiology. 16-20 September 1990, Stockholm, Sweden. Abstracts.
    Eur Heart J; 1990 Aug; 11 Suppl():1-487. PubMed ID: 2397739
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors for cardiovascular therapy: recent advances at the Tenth World Congress of Cardiology Washington DC, September 14-19, 1986.
    Opie LH
    Cardiovasc Drugs Ther; 1987; 1(1):111-2. PubMed ID: 2908699
    [No Abstract]   [Full Text] [Related]  

  • 10. ACE inhibitors and the kidney. Proceedings of a satellite symposium held in conjunction with the International Society of Hypertension. Kyoto, Japan, May 21, 1988.
    Nephron; 1990; 55 Suppl 1():1-98. PubMed ID: 2345588
    [No Abstract]   [Full Text] [Related]  

  • 11. [ACE inhibition in tissues. Decisive for prognosis?].
    MMW Fortschr Med; 2002 Mar; 144(11):60. PubMed ID: 12066521
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistance to ACE inhibitors. Myth or reality?].
    Aumont MC; Juliard JM
    Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1008-12. PubMed ID: 11603063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint XIIth World Congress of Cardiology and XVIth Congress of the European Society of Cardiology. September 10-14, 1994, Berlin, Germany. Abstracts.
    Eur Heart J; 1994 Aug; 15 Abstr Suppl():1-615. PubMed ID: 7988615
    [No Abstract]   [Full Text] [Related]  

  • 14. From vascular protection to secondary prevention in cardiovascular diseases. Proceedings of satellite symposium to the 16th Scientific Meeting of the International Society of Hypertension. Glasgow, United Kingdom, 23 June 1996.
    J Hypertens Suppl; 1996 Dec; 14(6):S1-53. PubMed ID: 9091612
    [No Abstract]   [Full Text] [Related]  

  • 15. [Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].
    Med Clin (Barc); 1991 Apr; 96(16):suppl 2 p.. PubMed ID: 2051826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy with ACE inhibitors. What kind of risk make them indispensible?].
    Kleber FX
    MMW Fortschr Med; 2000 Nov; 142(46):44-5. PubMed ID: 11132312
    [No Abstract]   [Full Text] [Related]  

  • 17. [The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors].
    Greminger P; Vetter W
    Schweiz Rundsch Med Prax; 1988 Jun; 77(24):673-9. PubMed ID: 3041532
    [No Abstract]   [Full Text] [Related]  

  • 18. Is hypertension a metabolic disease? Do we have to reevaluate our way of thinking? Proceedings of a satellite symposium to the 14th Congress of the European Society of Cardiology. Barcelona, Spain, September 2, 1992.
    Am Heart J; 1993 May; 125(5 Pt 2):1485-546. PubMed ID: 8097613
    [No Abstract]   [Full Text] [Related]  

  • 19. [ACE inhibitors in cardiovascular diseases symposium. Colon, January 1994].
    Z Kardiol; 1994; 83 Suppl 4():1-87. PubMed ID: 7856275
    [No Abstract]   [Full Text] [Related]  

  • 20. ACE inhibitors in cardiovascular disease. Which patient? Which drug? Which dose?
    Pellizzer AM; Krum H
    Aust Fam Physician; 1996 Jul; 25(7):1067-9, 1072-3, 1076-7. PubMed ID: 8768273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.